Promising new weight-loss drugs前景可观的新型减肥药物
One emerging drug helped one out of three diabetic patients lose up to a quarter of their body weight.

An alternative weight-loss jab to the GLP-1 drugs may be able to help people with type 2 diabetes lose a significant amount of their body weight. — dpa
An emerging weight-loss drug could help some obese people with type 2 diabetes shed up to a quarter of their body weight, while keeping blood sugar under control, a clinical trial has found.
Retatrutide works by mimicking three different hormones to control hunger and blood sugar, as well as speeding up metabolism.
Meat portions shrinking due to effects of weight-loss drugs
Understanding GLP-1 drugs, those popular weight-loss medications
Weight returns four times faster after stopping weight-loss drugs
Thank you for your report!
Malaysian tech outfit Katch launches NADI to help digitalise 1,000 wellness, fitness and sports businesses in Selangor by 2027
MySihat Expo 2026 set to become Malaysia's largest healthcare, wellness, sports and lifestyle festival
Global metabolic health market presents new growth opportunities for the international health and wellness industry
一种替代GLP-1类药物的减肥注射剂或许能够帮助2型糖尿病患者显著减轻体重。——德新社
一项临床试验发现,一种新兴的减肥药物可以帮助一些患有 2 型糖尿病的肥胖患者减掉高达四分之一的体重,同时还能控制血糖。
Retatrutide 的作用机制是模拟三种不同的激素来控制饥饿感和血糖,并加速新陈代谢。
减肥药的作用导致肉类摄入量减少
了解 GLP-1 类药物,这些流行的减肥药物
停止服用减肥药后,体重反弹速度会快四倍。
感谢您的报告!
马来西亚科技公司Katch推出NADI项目,旨在到2027年帮助雪兰莪州1000家健康、健身和体育企业实现数字化转型。
2026年MySihat Expo有望成为马来西亚规模最大的医疗保健、健康、体育和生活方式盛会。
全球代谢健康市场为国际健康和保健行业带来了新的增长机遇